Variant report
Variant | esv3436454 |
---|---|
Chromosome Location | chr11:93346554-93347752 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:141)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr11:93346833-93346836 | K562 | blood: | n/a | n/a |
2 | ARID3A | chr11:93347699-93347910 | K562 | blood: | n/a | n/a |
3 | ARID3A | chr11:93347293-93347963 | HepG2 | liver: | n/a | n/a |
4 | ARID3A | chr11:93346614-93346942 | HepG2 | liver: | n/a | n/a |
5 | BACH1 | chr11:93347641-93347890 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | CBX3 | chr11:93347544-93347976 | K562 | blood: | n/a | n/a |
7 | CEBPB | chr11:93347594-93347964 | HepG2 | liver: | n/a | n/a |
8 | CTCF | chr11:93347680-93347830 | HPAF | blood vessel: | n/a | n/a |
9 | CTCF | chr11:93347680-93347830 | GM12878 | blood: | n/a | n/a |
10 | CTCF | chr11:93347700-93347850 | GM12868 | blood: | n/a | n/a |
11 | CTCF | chr11:93347740-93347890 | MCF-7 | breast: | n/a | n/a |
12 | CTCF | chr11:93347740-93347890 | HRE | kidney: | n/a | n/a |
13 | CTCF | chr11:93347720-93347870 | Hela-S3 | cervix: | n/a | n/a |
14 | CTCF | chr11:93347708-93347829 | ProgFib | skin: | n/a | n/a |
15 | CTCF | chr11:93347660-93347810 | AG09319 | gingival: | n/a | n/a |
16 | CTCF | chr11:93347720-93347870 | HFF | foreskin: | n/a | n/a |
17 | CTCF | chr11:93347679-93347907 | MCF-7 | breast: | n/a | n/a |
18 | CTCF | chr11:93347740-93347890 | GM12872 | blood: | n/a | n/a |
19 | CTCF | chr11:93347692-93347885 | MCF-7 | breast: | n/a | n/a |
20 | CTCF | chr11:93347740-93347890 | GM12871 | blood: | n/a | n/a |
21 | CTCF | chr11:93347731-93347838 | Gliobla | brain: | n/a | n/a |
22 | CTCF | chr11:93347700-93347850 | WERI-Rb-1 | eye: | n/a | n/a |
23 | CTCF | chr11:93347720-93347870 | HL-60 | blood: | n/a | n/a |
24 | CTCF | chr11:93347720-93347870 | HEK293 | kidney: | n/a | n/a |
25 | CTCF | chr11:93347628-93347993 | HepG2 | liver: | n/a | n/a |
26 | CTCF | chr11:93347688-93347887 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | CTCF | chr11:93347700-93347850 | SK-N-SH_RA | brain: | n/a | n/a |
28 | CTCF | chr11:93347680-93347830 | GM12875 | blood: | n/a | n/a |
29 | CTCF | chr11:93347680-93347830 | HepG2 | liver: | n/a | n/a |
30 | CTCF | chr11:93347560-93347710 | HRPEpiC | eye: | n/a | n/a |
31 | CTCF | chr11:93347710-93347884 | Fibrobl | skin: | n/a | n/a |
32 | CTCF | chr11:93347700-93347850 | HA-sp | spinal cord: | n/a | n/a |
33 | CTCF | chr11:93347736-93347827 | GM10248 | blood: | n/a | n/a |
34 | CTCF | chr11:93347660-93347810 | GM12864 | blood: | n/a | n/a |
35 | CTCF | chr11:93347726-93347837 | GM12878 | blood: | n/a | n/a |
36 | CTCF | chr11:93347720-93347870 | SAEC | small airway: | n/a | n/a |
37 | CTCF | chr11:93347660-93347810 | AG10803 | skin: | n/a | n/a |
38 | CTCF | chr11:93347700-93347850 | Caco-2 | colon: | n/a | n/a |
39 | CTCF | chr11:93347720-93347870 | GM12874 | blood: | n/a | n/a |
40 | CTCF | chr11:93347660-93347810 | GM12867 | blood: | n/a | n/a |
41 | CTCF | chr11:93347720-93347870 | HPF | lung: | n/a | n/a |
42 | CTCF | chr11:93347745-93347819 | GM10266 | blood: | n/a | n/a |
43 | CTCF | chr11:93347680-93347830 | HEK293 | kidney: | n/a | n/a |
44 | CTCF | chr11:93347664-93347915 | HepG2 | liver: | n/a | n/a |
45 | CTCF | chr11:93347740-93347890 | HCPEpiC | choroid plexus: | n/a | n/a |
46 | CTCF | chr11:93347720-93347870 | BJ | skin: | n/a | n/a |
47 | CTCF | chr11:93347720-93347870 | AG04450 | lung: | n/a | n/a |
48 | CTCF | chr11:93347720-93347870 | HFF-Myc | foreskin: | n/a | n/a |
49 | CTCF | chr11:93347631-93347915 | K562 | blood: | n/a | n/a |
50 | CTCF | chr11:93347740-93347890 | HRPEpiC | eye: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000255515 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113442960 | chr11:93346577-93346578 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149505047 | chr11:93346578-93346579 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143984048 | chr11:93346587-93346588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs35498772 | chr11:93346653-93346654 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs550530612 | chr11:93346685-93346686 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs565484006 | chr11:93346742-93346743 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs7123348 | chr11:93346743-93346744 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs536504547 | chr11:93346782-93346783 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs554500539 | chr11:93346827-93346828 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs138432909 | chr11:93346832-93346833 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs200143524 | chr11:93346847-93346848 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs200862753 | chr11:93346848-93346849 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs202058582 | chr11:93346851-93346852 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs201082904 | chr11:93346854-93346855 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs543293349 | chr11:93346856-93346857 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs201231884 | chr11:93346880-93346881 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs534156819 | chr11:93346885-93346886 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs149854623 | chr11:93346889-93346890 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs12146696 | chr11:93346895-93346896 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs9737265 | chr11:93346904-93346905 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs57014027 | chr11:93346918-93346919 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs61918528 | chr11:93346919-93346920 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs202016460 | chr11:93346925-93346926 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs9734462 | chr11:93346937-93346938 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs534006125 | chr11:93346958-93346959 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs556957132 | chr11:93346974-93346975 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs140191395 | chr11:93347009-93347010 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs575351367 | chr11:93347035-93347036 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs182780964 | chr11:93347058-93347059 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs200242919 | chr11:93347086-93347087 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs143866961 | chr11:93347134-93347135 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs146873402 | chr11:93347188-93347189 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs200106102 | chr11:93347209-93347210 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540020812 | chr11:93347214-93347215 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs564757799 | chr11:93347216-93347217 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs200524432 | chr11:93347226-93347227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs112448454 | chr11:93347237-93347238 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs149152659 | chr11:93347257-93347258 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs146411887 | chr11:93347269-93347270 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs188294922 | chr11:93347287-93347288 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs376821290 | chr11:93347337-93347338 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs112442604 | chr11:93347382-93347383 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs548840774 | chr11:93347417-93347418 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs61918529 | chr11:93347457-93347458 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs192191376 | chr11:93347480-93347481 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs147867627 | chr11:93347487-93347488 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs571066520 | chr11:93347496-93347497 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs538728061 | chr11:93347523-93347524 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs557140626 | chr11:93347544-93347545 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs373054656 | chr11:93347555-93347556 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21499728 | CNVD |
Breast cancer | 19181860 | CNVD |
Breast cancer | 17603634 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:93342800-93346800 | Enhancers | Fetal Intestine Large | intestine |
2 | chr11:93343200-93346600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
3 | chr11:93343200-93346600 | Enhancers | Stomach Mucosa | stomach |
4 | chr11:93344200-93346800 | Enhancers | Primary monocytes fromperipheralblood | blood |
5 | chr11:93344400-93346600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
6 | chr11:93344400-93347600 | Enhancers | Fetal Intestine Small | intestine |
7 | chr11:93344800-93347400 | Weak transcription | Gastric | stomach |
8 | chr11:93345000-93346800 | Enhancers | Duodenum Mucosa | Duodenum |
9 | chr11:93346400-93346600 | Enhancers | Small Intestine | intestine |
10 | chr11:93346800-93347200 | Weak transcription | Duodenum Mucosa | Duodenum |
11 | chr11:93346800-93347600 | Weak transcription | Fetal Intestine Large | intestine |
12 | chr11:93347200-93348200 | Enhancers | Duodenum Mucosa | Duodenum |
13 | chr11:93347400-93347600 | Enhancers | Gastric | stomach |
14 | chr11:93347600-93347800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr11:93347600-93347800 | Enhancers | Fetal Intestine Large | intestine |
16 | chr11:93347600-93348000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
17 | chr11:93347600-93348400 | Enhancers | HepG2 | liver |